Deliver toQatar
2024-25 Guide to Medications for the Treatment of Diabetes Mellitus

Description:

The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association’s Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
• Neuropathy
• Chronic Kidney Disease
• Retinopathy
• Hypoglycemia
• Obesity
• Depression


Editorial Reviews

About the Author

JOHN R. WHITE, JR., PA-C, PHARMD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at Washington State University College of Pharmacy. Dr. White is the author of three books, more than 30 book chapters, and over 150 manuscripts on diabetes medications. He is currently Associate Editor of Clinical Diabetes.

JOSHUA J. NUEMILLER, PHARMD, CDCES, FADCES, FASCP, is Vice Chair and Allen I. White Distinguished Professor, Pharmacotherapy, at the College of Pharmacy and Pharmaceutical Sciences at Washington State University. Dr. Neumiller currently serves as the ADA’s president-elect for healthcare & education and is the author of
Practical Insulin.

Details:

2024-25 Guide to Medications for the Treatment of Diabetes Mellitus

Product ID: U1580408389
|

Returns & Warranty policies

Imported From: United States

At BOLO, we work hard to ensure the products you receive are new, genuine, and sourced from reputable suppliers.

Every product in the BOLO catalogue is sourced through our Verified Global Supply Network of verified sellers, authorized distributors or directly from the manufacturer.

Each product undergoes thorough inspection and verification at our consolidation and fulfilment centers to ensure it meets our strict authenticity and quality standards before being shipped and delivered to you.

If you ever have concerns regarding the authenticity of a product purchased from us, please contact Bolo Support. We will review your inquiry promptly and, if necessary, provide documentation verifying authenticity or offer a suitable resolution.

Your trust is our top priority, and we are committed to maintaining transparency and integrity in every transaction.

While we strive to display accurate information, variations in packaging, labeling, instructions, or formulation may occasionally occur due to regional differences or supplier updates. For detailed or manufacturer-specific information, please contact the brand directly or reach out to BOLO Support for assistance.

Unless otherwise stated, all prices displayed on the product page include applicable taxes and import duties.

BOLO operates in accordance with the laws and regulations of Qatar. Any items found to be restricted or prohibited for sale within the Qatar will be cancelled prior to shipment. We take proactive measures to ensure that only products permitted for sale in Qatar are listed on our website.

All items are shipped by air, and any products classified as “Dangerous Goods (DG)” under IATA regulations will be removed from the order and cancelled.

All orders are processed manually, and we make every effort to process them promptly once confirmed. Products cancelled due to the above reasons will be permanently removed from listings across the website.

2024-25 Guide to Medications for the Treatment of Diabetes Mellitus

Product ID: U1580408389
2024-25 Guide to Medications for the Treatment of Diabetes Mellitus-0
|

Returns & Warranty policies

Imported From: United States

At BOLO, we work hard to ensure the products you receive are new, genuine, and sourced from reputable suppliers.

Every product in the BOLO catalogue is sourced through our Verified Global Supply Network of verified sellers, authorized distributors or directly from the manufacturer.

Each product undergoes thorough inspection and verification at our consolidation and fulfilment centers to ensure it meets our strict authenticity and quality standards before being shipped and delivered to you.

If you ever have concerns regarding the authenticity of a product purchased from us, please contact Bolo Support. We will review your inquiry promptly and, if necessary, provide documentation verifying authenticity or offer a suitable resolution.

Your trust is our top priority, and we are committed to maintaining transparency and integrity in every transaction.

While we strive to display accurate information, variations in packaging, labeling, instructions, or formulation may occasionally occur due to regional differences or supplier updates. For detailed or manufacturer-specific information, please contact the brand directly or reach out to BOLO Support for assistance.

Unless otherwise stated, all prices displayed on the product page include applicable taxes and import duties.

BOLO operates in accordance with the laws and regulations of Qatar. Any items found to be restricted or prohibited for sale within the Qatar will be cancelled prior to shipment. We take proactive measures to ensure that only products permitted for sale in Qatar are listed on our website.

All items are shipped by air, and any products classified as “Dangerous Goods (DG)” under IATA regulations will be removed from the order and cancelled.

All orders are processed manually, and we make every effort to process them promptly once confirmed. Products cancelled due to the above reasons will be permanently removed from listings across the website.

Description:

The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association’s Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
• Neuropathy
• Chronic Kidney Disease
• Retinopathy
• Hypoglycemia
• Obesity
• Depression


Editorial Reviews

About the Author

JOHN R. WHITE, JR., PA-C, PHARMD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at Washington State University College of Pharmacy. Dr. White is the author of three books, more than 30 book chapters, and over 150 manuscripts on diabetes medications. He is currently Associate Editor of Clinical Diabetes.

JOSHUA J. NUEMILLER, PHARMD, CDCES, FADCES, FASCP, is Vice Chair and Allen I. White Distinguished Professor, Pharmacotherapy, at the College of Pharmacy and Pharmaceutical Sciences at Washington State University. Dr. Neumiller currently serves as the ADA’s president-elect for healthcare & education and is the author of
Practical Insulin.

Details: